Cours Acro Biomedical Co., Ltd. Other OTC
Actions
ACBM
US0048921052
Transformation des aliments
CA 2021 | 1,2 M 1,1 M | CA 2022 | 658 k 605 k | Capitalisation | 270 M 248 M |
---|---|---|---|---|---|
Résultat net 2021 | -7 M -6,43 M | Résultat net 2022 | -15 M -13,79 M | VE / CA 2021 | 233 x |
Trésorerie nette 2021 | 24,08 k 22,13 k | Dette nette 2022 | 98,69 k 90,7 k | VE / CA 2022 | 410 x |
PER 2021 |
-32,5
x | PER 2022 |
-17
x | Employés | - |
Rendement 2021 * |
-
| Rendement 2022 |
-
| Flottant | 50,03% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Pao Chi Chu
CEO | Chief Executive Officer | 70 | 30/01/17 |
Shi Ming Li
CTO | Chief Tech/Sci/R&D Officer | - | - |
Jer Li Lin
CTO | Chief Tech/Sci/R&D Officer | - | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Pao Chi Chu
CEO | Chief Executive Officer | 70 | 30/01/17 |
Cheng Hsiang Kao
PRN | Corporate Officer/Principal | - | - |
Varia. 1 janv. | Capi. | |
---|---|---|
+13,21% | 8,01 Md | |
+1,64% | 7,36 Md | |
+12,30% | 6,54 Md | |
-6,99% | 3,73 Md | |
-7,71% | 3,42 Md | |
-4,78% | 1,24 Md | |
+12,61% | 935 M | |
-42,96% | 886 M | |
-21,93% | 827 M |